Knollwood Investment Advisory, LLC
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1999346
HUNT VALLEY, MD
Position in ABOS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,348,121
+$504,838 QoQ
Shares Held
1,628,510
0.0% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#8
of 96 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Knollwood Investment Advisory, LLC holds $8,491,864 across 5 Biotechnology names. ABOS ranks #1 (51.2% of the industry book) .
All Filings in ABOS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,348,121 | 1,628,510 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,843,283 | 1,628,510 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,436,156 | 1,628,510 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,784,752 | 1,628,510 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,889,071 | 1,628,510 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,791,361 | 1,628,510 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,801,037 | 1,628,510 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,038,704 | 1,628,510 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,940,994 | 1,628,510 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,595,465 | 1,628,510 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,253,478 | 1,628,510 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,758,316 | 1,628,510 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,073,633 | 1,678,510 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $6,814,750 | 1,678,510 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $9,063,954 | 1,678,510 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||